NIH Cuts Out Soviet Lab In Grant To Emigre Geneticist

WASHINGTON--NIH has balked at what would have been unprecedented funding of the Soviet component of collaborative research with a Soviet émigré now in the United States (The Scientist, April 2, 1990, page 1). But the scientist, geneticist Valery Soyfer, says that he'll be able to carry out most of the work by having his collaborator, molecular biologist Maxim Frank-Kamenet-skii, spend time in Soyfer's new laboratory at George Mason University. Persecuted and penniless in the Sovi

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WASHINGTON--NIH has balked at what would have been unprecedented funding of the Soviet component of collaborative research with a Soviet émigré now in the United States (The Scientist, April 2, 1990, page 1). But the scientist, geneticist Valery Soyfer, says that he'll be able to carry out most of the work by having his collaborator, molecular biologist Maxim Frank-Kamenet-skii, spend time in Soyfer's new laboratory at George Mason University.

Persecuted and penniless in the Soviet Union, Soyfer was a 10-year critic of the politicization of Soviet science who hoped that his fortunes would improve after he arrived in the United States. Two years after he was allowed to emigrate, Soyfer is still a "wanted" man. But this time he has no complaints.

Last month, Soyfer learned that NIH wants him to have $121,000 this year as part of a three-year grant to learn more about the triple helix DNA structure. ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies